<DOC>
	<DOCNO>NCT02953821</DOCNO>
	<brief_summary>Subjects active systemic lupus erythematosus ( SLE ) randomize receive Acthar placebo . Active treatment continue 24 week . Efficacy assess multiple timepoints use SLE Responder Index ( SRI ) , SLEDAI-2K , BILAG , PGA , CLASI 28 Joint Count</brief_summary>
	<brief_title>A Study Assess Efficacy Safety H.P . Acthar® Gel Subjects With Active Systemic Lupus Erythematosus ( SLE )</brief_title>
	<detailed_description>This randomize , placebo control , double blind study . Following screening period 28 day , subject active systemic lupus erythematosus ( SLE ) include moderate severe rash and/or arthritis despite corticosteroid therapy randomize 1:1 ratio receive 1 mL ( 80 Units [ U ] ) Acthar match placebo . During Weeks 1 4 , 1 mL ( 80 U ) Acthar volume match placebo administer subcutaneously ( SC ) every day . For remainder study ( Weeks 5 24 ) , Acthar 1 mL ( 80 U ) volume match placebo administer SC 2x/week .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>1 . Subjects must ≥ 18 year age Screening Visit 2 . Subjects must diagnosis SLE accord American College Rheumatology revise criterion ( fulfil ≥ 4 criterion ) . 3 . Subjects must active SLE demonstrate SLEDAI2K score ≥ 6 Screening Visit clinical SLEDAI ( exclude laboratory result ) score ≥ 4 Screening Randomization Visits . Points arthritis and/or rash must present Screening Randomization Visits . 4 . Subjects must document history positive antinuclear antibody . 5 . Subjects must document history autoantibody least 1 follow : antids DNA , antiSmith , anticardiolipin . 6 . Subjects must prednisone ( prednisone equivalent ) ≥ 8 week prior Screening Visit stable dose 7.5 mg 30 mg prednisone ( prednisone equivalent ) ≥ 4 week prior Screening Visit . Exclusion criterion : 1 . Subject history sensitivity ACTH preparation porcine product 2 . Subject active lupus nephritis 3 . Subject active CNS manifestation SLE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>